Table 1

Surveys of screening preference for colorectal cancer
First Author
 Subjects Age Range
 N =
 Comparison
 Preference
 Comment
Steine9
 GI Patients 45–79 y
 190
 BE v C
 BE
 Post hoc
Durdey10
 GI Patients 19–88 y
 66
 BE v C
 C
 Post hoc
VanNess11
 GI Patients 20–84 y
 189
 BE v C
 C
 Post hoc
Elwood20
 Relatives of GI Patients 45–70 y
 232
 FS v C
 FS = C
 RCT; Subjects offered FS or C and differential compliance measured
Dominitz12
 VAOP 50–75 y
 62
 FS v C
 FS
 Time trade off measure Least for FS.
Frew13
 PCOP >25 y
 2294
 FOBT v FS
 FOBT
 Willingness to pay primary endpoint. Preference also collected.
Leard14
 PCOP 50–75 y
 100
 FOBT, FS, BE, C
 C preferred FOBT more likely to be done.
 Post hoc 93% previously screened
Dolan17
 PCOP >50 y
 96
 FOBT, FS, BE, C
 FOBT
 DARCT
Pignone15
 PCOP 50–75 y
 227
 FOBT v FS
 FOBT
 DARCT
Pignone18
 PCOP 50–75 y
 146
 FOBT v FS
 FOBT
 4 levels of survey after varying quantities of information on colon cancer risk, conduct, test accuracy, cost.
Wolf16
 PCOP >65 y
 57
 FOBT v FS
 FOBT
 DARCT
Nelson
 Non-patients 18–54 y
 80
 FOBT, FS, BE, C
 FOBT

GI Patients; Gastroenterology patients

BE; Barium enema.

C; Colonoscopy

FS; Fiberoptic sigmoidoscopy

FOBT; Fecal Occult Blot Testing

Post hoc; Preference measured after undergoing one or more of the above screening tests.

RCT; Randomised Controlled Trial

VAOP; Veteran's administration hospital outpatients

PCOP; Primary care outpatients

DARCT; Randomised trial to investigate the effectiveness of decision aids in increasing screening participation

Nelson and Schwartz BMC Cancer 2004 4:76   doi:10.1186/1471-2407-4-76